Share this post on:

Product Name :
Migoprotafib

Search keywords :
Migoprotafib

drugId :
null

Target Vo:
Src homology phosphotyrosyl phosphatase 2

Target Vo Short Name :
SHP2

Moa_Name:
Src homology phosphotyrosyl phosphatase 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Relay Therapeutics Inc

Active Company_Name :
F. Hoffmann-La Roche Ag

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ATG3 Rabbit mAb Autophagy
Synaptophysin (Y20P21) Mouse mAb web
PDX1 Antibody: PDX1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to PDX1. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related